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Abstract
Site-directed mutagenesis was performed on genes encoding HlgA and HlgC, two of the three proteins expressed from
 .the staphylococcal g-hemolysin locus, which originate two pore-forming toxins HlgAqHlgB, HlgCqHlgB . As related
proteins, HlgA and HlgC were found to bind first to cell membranes. Amino acid substitutions concerned residues that
would predictably disrupt a 13 amino acid conserved b-sheet of the Chou and Fasman secondary structure prediction. The
 .  .mutation of a threonin into an aspartic acid residue from HlgA T28D and from HlgC T30D that would break this
predicted N-terminal structure lowered dramatically the biological activities on purely lipidic vesicles, erythrocytes and
polymorphonuclear cells. The change in secondary structure was confirmed by Fourier Transformed Infrared spectroscopy.
The binding of mutated and native proteins at the same kind of sites onto polymorphonuclear cells was evidenced with flow
cytometry and fluorescein-labelled anti-class S antibodies or wild type HlgA or HlgC. However, the subsequent binding of
fluorescein-labelled HlgB to membrane-bound mutated HlgA or HlgC complexes was inhibited. In conclusion, the first
binding of class S components is essential for the subsequent binding of class F components, and a predicted b-sheet seems
to be at least one of the functional domains involved. q 1997 Elsevier Science B.V.
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Abbreviations: PMN, polymorphonuclear cells; SUV, small
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1. Introduction
The locus encoding the g-hemolysin from Staphy-
lococcus aureus Smith 5R, a methicillin-resistant
strain RIMD 310925, P83 and ATCC 49775 strains
w xwas described as composed of three genes 1–4 .
Two of the corresponding proteins, HlgA and HlgC
have primary structures related to the recently de-
 .scribed LukS-PV 62–65% identity and are consid-
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w xered as class S proteins 4 . The third protein, HlgB is
 .related to LukF-PV 72% identity and considered as
a class F protein. Similarly to the pair LukS-PVq
LukF-PV which forms the Panton-Valentine leuco-
w xcidin 5 , the g-hemolysins actually comprise two
pairs, e.g., HlgAqHlgB, HlgCqHlgB. The locus
encoding g-hemolysin is largely distributed among S.
aureus strains, whereas that encoding the Panton-
Valentine leucocidin is encountered in only 2% of
w xstrains mainly associated with furuncles 6,7 . A 25–
30% identity score was found between components
w xof class S and class F 1,4 which may account for a
similar folding when integrated into membranes.
In this work we demonstrate that the two g-hemo-
lysins are pore-forming toxins as the Panton-Valen-
w xtine leucocidin 8 . Logically, one can expect similar
biological features for these compounds, e.g., bind-
ing, components interaction, oligomerisation, and for-
mation of the pore. It was reported that LukS-PV and
 . w xHlgA class S components bind first to PMN 9,10
w xand to rabbit red blood cells 11 , respectively. How-
 .ever, HlgB class F component was reported to bind
w xprimarily onto human RBC 11 . Pairs constituting
g-hemolysin are leucotoxic for various mammalian
w xPMN, monocytes and macrophages 3,4 , inducing
winflammatory response of host defence cells 9,12–
x14 . However, HlgCqHlgB exhibits a hemolytic
activity very much lower than that of HlgAqHlgB
on both rabbit and human erythrocytes.
The different membrane ligands of class S compo-
nents remain unknown, as well as the interaction
between class F components and membrane-bound
class S components complexes. Furthermore, the stoi-
chiometric arrangement of the two synergistic pro-
teins participating in pore-formation has still to be
w xdefined clearly 9 . The synergistic action of two
different proteins and the various cell specificities
pertaining to the different pairs of proteins make
these toxins rather peculiar. Although the toxic pro-
cess of such molecules may be the result of pore-for-
mation, other interactions with cell signaling proteins
cannot be excluded.
In an attempt to study structure–function relation-
ships within these molecules, a single amino acid
substitution was designed to disrupt a part of a
predicted secondary structure appearing in both HlgA
w xand HlgC and also in LukS-PV 15 . The biological
activity of the purified engineered proteins was anal-
ysed on human circulating PMN, rabbit erythrocytes,
and small unilamellar vesicles.
2. Materials and methods
2.1. Plasmids and mutagenesis
DNA-modifying enzymes were used as recom-
mended by the manufacturers Gibco-Bethesda Re-
search Laboratories and New England Biolabs. Bev-
.erly, MA . The hlg locus of S. aureus ATCC 49775
 .sequence EMBL Library Databank no. X81586 was
w xpreviously cloned into the pUC 19 plasmid 16 .
 . XBriefly, pairs of oligonucleotides: 1 3 5 -
AATAAATCTTTTAAACATAATGCTA-3X 27, cou-
pled to 353 5X-TCAAATTGAATGTTTTGATCTA-
TAGCTAATCGT-3X 326 from hlgA sequence deter-
 .mining a HlgA T28D mutated protein and 2 1475
5X-GCTTTTAGCATTCCAAACAAAAA-3X 1497
coupled to 1841 5X-GAATTGGATATTTTGATC-
CACGCCCCATTTATTA C-3X 1807 or 2132 5X-GT-
TAAATGATCCT TTACCACCAAG-3X 2109 from
hlgC sequence determining mutated HlgC T30D, and
HlgC N129K, respectively, were used for short DNA
w xfragments amplification 17 . Amplifications were
performed in 100 ml containing 10 ng of recombinant
plasmid and 2 U of Taq DNA polymerase Gibco-
.BRL . Operating conditions were as follows: one
denaturing step of 4 min at 948C; 20 cycles of 3 steps
of 1 min 30 s at 928C, 1 min 30 s at 488C, 1 min 30 s
at 728C; an ending step of 3 min at 728C. The
amplified DNA fragments were electrophoresed on
 .1.5% wrv agarose gel and electroeluted in order to
be used in a second amplification with the oligo-
nucleotides 1396 5X-AATGTCTTGCTTTTATTTTT-
3X 1377 and 2845 5X-CTGCAGCTTTAAG-
CACTAAAG-3X 2825, thus amplifying whole hlgA
and hlgC genes, respectively. Secondary amplifica-
tions were performed as followed: one denaturing
step of 4 min at 948C; 20 cycles of 3 steps of 1 min
30 s at 928C, 1 min 30 s at 548C, 4 min 30 s at 728C,
and 5 min at 728C. The electroeluted amplified DNA
fragments were then ligated to the TrA ended plas-
TM  .mid pCR II RD Systems Ltd - London , used to
 . Xtransform Escherichia coli E. coli Inva F strain
w  - q .endA1, recA1, hsdR17 r k, m k , supE44, l-,
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thi1, gyrA, relA1, f 80, lacZ DM15 D lacZYA-
. q X x w xargF , deoR , F , and sequenced 18 in both strands
with T7 DNA polymerase Pharmacia, Uppsala, Swe-
.den . DNA analyses and structure predictions were
made by using DNAStar Software DNAStar Ltd-
.London .
2.2. Purification of mutated proteins
For each of the mutated genes as well as for the
wild-type gene, recombinant Inva FX E. coli strains
were grown at 378C during 18 h in 2-liter Erlenmeyer
flasks filled with 1 liter of 2=TY medium – 100
mgrml ampicillin. Bacteria were harvested by a 10-
min centrifugation at 7000=g and resuspended as
 .30% wrvol in 50 mM NaH PO , 1 mM EDTA,2 4
 .0.5 mM DTT pH 7.0 . Bacteria were then ground
under a 130 megaPascal pressure in a FrenchPress
 .SLM Instruments, Urbana, USA at 48C. Bacterial
debris were removed by a 35-min ultracentrifugation
 .at 55 000=g in a Ti60 rotor Beckman at 48C.
Supernatants were dialysed against 50 mM NaH PO ,2 4
 .1 mM EDTA, 0.5 mM DTT pH 7.0 . The mutated
proteins were purified by the same procedure as
previously reported for the wild-type HlgA or HlgC
w x4,19 . They were stored at y808C at a 1 mgrml
concentration after being analysed by SDS-PAGE
w x w  .20 on PHAST -System Pharmacia .
2.3. Labelling of antibodies and purified HlgB with
([ ] )5- 4, 6-dichlorotriazin-2-YL amino -fluorescein
( )DTAF
Affinity-purified rabbit polyclonal anti-S compo-
nent antibodies and purified HlgB were adjusted to 1
 .mgrml in 0.2 M NaHCO pH 9.0 and mixed for 203
min at room temperature with 0.1 volume of 2 M
 .DTAF solubilised in 1 M NaHCO pH 9.0 . The3
w xcoupling reaction 21 was stopped by equilibrating
 .the solution to 50 mM NH Cl pH 8.0 for 2 H at4
48C. Free DTAF was discarded by desalting in a
 .PD10 column Pharmacia , and proteins were equili-
 .brated in 30 mM Hepes, 0.15 M NaCl pH 7.5 .
DTAF coupling was measured by the determination
of the concentration of protein as assayed by Brad-
ford coloration compared to the bound fluorescein
concentration measured at OD e s61 000491 nm M
y1 y1.M .cm . HlgB was labelled with DTAF in a 1:1
mol ratio and conserved more than 95% of the bio-
logical activity of the wild HlgB when combined
with HlgA or HlgC.
2.4. Secondary structure determinations by attenu-
ated total reflectance – Fourier transformed infrared
( )ATR-FTIR spectroscopy
ATR-FTIR spectra were recorded on a Bio-Rad
FTS 185 FTIR spectrometer equipped with a DTGS
detector with CsI window, a KBr beamsplitter and an
ATR attachment by Specac. Typically, 32 interfero-
grams were collected, Fourier transformed to a nomi-
nal resolution of 0.5 cmy1 and averaged. The instru-
ment was constantly purged with dry air. Spectra
were corrected by subtracting a background obtained
with the ATR crystal and no sample. The absorbance
of residual H O was subtracted to give an almost flat2
baseline between 1880 and 1720 cmy1. Before analy-
sis the leukotoxins were extensively dialysed against
 .three changes of 10 mM Hepes pH 7.0 . For the
experiment, 28 to 40 mg of HlgA, HlgA T28D,
HlgC, and HlgC T30D contained in 40 ml of the
given leukotoxin solution were deposited and dried in
a thin layer on one side of a 10-reflections Ge crystal
 .458 cut : the crystal was housed in a liquid cell and
flushed with D O-saturated nitrogen for 45 min be-2
fore collecting the reported spectra.
The ATR-FTIR spectra were processed using the
Bio-Rad Win-IR software. Spectra were deresolved
to 2 cmy1 and then the amide IX band, between 1600
and 1700 cmy1, was curve-fitted with a sum of
Lorentzians, using the nonlinear least squares fitting
w xof Levenberg-Marquardt method 22 . No parameter
was constrained. The relative contents of secondary
structure elements were estimated by dividing the
areas of the individual peaks, assigned to particular
w xsecondary structures according to Byler and Susi 23 ,
by the area of the whole amide IX band; the compo-
nents around 1610 cmy1, resulting from the side
chains, were excluded.
2.5. Permeabilisation of lipid ˝esicles
 .Small unilamellar vesicles SUV were prepared as
follows: an equimolar mixture of phosphatidylcholine
 . PC, Avanti Polar Lipids and cholesterol Cho,
.Fluka 1:1 at a total lipid concentration of 2 mgrml
was sonicated for 1 h in a solution containing calcein
 .80 mM Sigma , whose pH was adjusted at 7.0 with
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NaOH. Titanium particles released by the sonotrode
during sonication were removed by centrifugation.
SUV were washed in a Sephadex-G25 column to
remove free calcein, using a buffer containing 30 mM
 .Tris-HCl, 100 mM NaCl, 1 mM EDTA pH 7.0 .
The permeabilising activity of SUV by the toxins
was assayed by measuring the extent of calcein re-
w xlease 24 . In a 1-cm plastic cuvette a total volume of
1.2 ml of the above buffer containing a final lipid
concentration around 10 mgrml and the indicated
concentrations of the assayed toxins were incubated
under continuous stirring. After the addition of the
 . toxin, the fluorescence F emitted at 520 nm excita-
.tion at 494 nm , increased as a consequence of the
dequenching of the internal dye when diluted in the
external medium. Maximum release was determined
by addition of 1 ml Triton X-100. The extent of
permeabilisation was calculated as:
P % s100= F yF r F yF .  .  .final initial maximal initial
where F is the value of fluorescence before theinitial
addition of the toxin, F the value reached atfinal
equilibrium, and F the value obtained withmaximal
Triton X-100.
2.6. Determination of the hemolytic acti˝ity
Fresh venous blood was collected from rabbit in
 .EDTA 6 mM. Rabbit red blood cells RRBC were
prepared by washing thrice 10 min centrifugation at
.700=g, broom temperature in a buffer containing
30 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA pH
.7.0 . The time course of the RRBC lysis in the
presence of the different toxins was followed by
measuring the turbidity at 650 nm in the washing
buffer at 258C, using a kinetic 96-well microplate
 .reader Molecular Devices UVmax , as already de-
w xscribed 25 . Each well contained the specified con-
centrations of the indicated toxins and RRBC at a
 .concentration of 0.13% vrv , which corresponds to
an initial A of 0.1, in a final volume of 200 ml650nm
of the same buffer. When a couple of toxins was
assayed, both components were added at the same
concentration, and serially two-fold diluted along a
line of the microplate. In competition studies of a
native with a mutant toxin, the concentration of the
 .wild-type toxins HlgAqHlgB or HlgCqHlgB was
constant all along the line, while the mutant was
serially diluted. The 96 wells were stirred and read
every 8 s for 45 min of reaction. The percentage of
hemolysis was calculated as:
Hemolysis % s100= A yA r .  .initial final
A yA .initial waterylysed
where A is the absorbance before adding theinitial
toxin, A that after the addition of the toxin, andfinal
A the absorbance obtained when the RRBCwater-lysed
were completely lysed in water. The maximal rate of
hemolysis, V , was the largest slope calculated inmax
the absorbance vs. time curve normalised by dividing
 .by A yA .initial water-lysed
For the end-point measurements, the assay was
performed differently. In a total volume of 500 ml,
 .RRBC at the same final concentration as above
were incubated with the toxins for 30 min at 378C.
 .Intact cells were pelleted 15 800=g, 3 min and the
released hemoglobin in the supernatant was read at
415 nm. The hemolytic activity was calculated as:
Hemolysis % s100= A yA r .  .qtoxin ytoxin
A yA .waterylysed ytoxin
where A and A are the reading with andqtoxin ytoxin
without toxin, respectively.
2.7. Preparation of leucocytes
w  .Five ml of Plasmion Lab. Roger Bellon, France
were added to 14 ml of buffy-coats from healthy
 .donors diluted with 6 ml of 9‰ wrv NaCl and left
to sediment for 30 min. Supernatant leucocytes sus-
pension were harvested and the residual erythrocytes
contaminating were lysed for 10 min by completing
to 50 ml with 0.16 M NH Cl. After washing, cells4
 6 .were resuspended 5=10 cellsrml in 140 mM
NaCl, 5 mM KCl, 10 mM glucose, 0.1 mM ethylene
 . X Xglycol-bis beta-aminoethyl ether N, N, N ,N -tetra-
acetic acid, 10 mM Hepes and 3 mM Tris-base pH
.7.3 . The latter buffer was also used to wash cells
treated with toxins and antibodies as well as for
competition assays before flow cytometry analysis.
2.8. Flow cytometry measurements
Before further experiments, rapid leucocytolytic
and hemolytic assays were achieved as previously
w xreported 4 . Flow cytometry measurements were
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w made using a FACSort cytometer Becton-Dickin-
.son, Le Pont de Claix, France equipped with a 15
 .mW argon laser tuned at 488 nm. Forward FSC and
 .side SSC light scatter dot plots acquired from 5000
 6 .purified white cells 10 cellsrml were usually gated
w x for PMN 10 . The fluorescence light 1 FL1: l sEM
.530 nm was used to record the DTAF fluorescence
 .and the fluorescence light 3 FL3: l s585 nmEM
was used to record the fluorescence of ethidium. The
fluorescence of ethidium which increases when it is
bound to nucleic acids was used as an indicator of the
formation of pores through the cell membrane as
w xpreviously described in the absence of calcium 10 .
Data were calculated from quadriplicate assays by
 .Lysis 2 TM software Becton-Dickinson, France .
2.9. Binding capabilities determination
Two methods were used to determine the binding
 .of both components: 1 the binding of the class S
components was measured by the fixation of fluores-
cent anti-class S components antibodies. The PMN
were incubated with increasing amounts of HlgA or
HlgC, and after washing, a 15 min subsequent incu-
 .bation with fluorescent anti-S antibodies 2.5 mgrml
 .was performed at room temperature; 2 the class S
components capabilities to bind the class F compo-
nent were estimated by the binding of fluorescent
 .DTAF-HlgB 0.75 nM . The results were calculated
as percent of the mean fluorescence obtained from
5000 cells for 3 nM HlgA or HlgC. A concentration
of 3 nM in HlgA and HlgC was used in the rest of
this study for mutants comparison and competition
since this value is close to the concentration where
the specific binding is saturated.
3. Results
3.1. Secondary structure predictions
However, class S proteins, on one hand, and class
F proteins, on the other hand, harbour from 60 to
98% sequence identity. Moreover, secondary struc-
w xture predictions 15 revealed significant homologies.
As an attempt to verify the significance of these
observations and determine which of the predicted
Fig. 1. A: Secondary structures predictions of HlgC, HlgC T30D, HlgC T30DrD36N, HlgC N129K, HlgA, and HlgA T28D.
 .  . w x  .Alpha-helices I and beta-sheet B predictions were obtained by computed Chou and Fasman 3 algorithms DNAStar Ltd . B:
 .  .SDS-PAGE of the purified mutated proteins 50 ng loaded . Lanes 1 and 8: apparent molecular mass ladder Pharmacia . Lane 2: HlgC.
Lane 3: HlgC T30D. Lane 4: HlgC T30DrD36N. Lane 5: HlgC N129K. Lane 6: HlgA. Lane 7: HlgA T28D.
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secondary structures may have an important role in
the cascade of events determining pore-formation, we
introduced amino acid substitutions that would, pre-
dictably, disrupt some conserved secondary structures
of the class S proteins. These latter components were
considered as the most critical to study, since they are
binding to target cell membranes in first place.
Two mutations concerned a predicted and con-
 .served 13 amino acid-long b-sheet Fig. 1A in the
N-terminal extremity of HlgA and HlgC HlgA T28D
.and HlgC T30D . A third one HlgC T30DrD36N
was obtained simultaneously to HlgC T30D and was
analysed because of a predicted partial restoration of
the b-sheet along 6 amino acids. The HlgC N129K
was induced in order to modify a region GYNIGG-
.GNFQS having homology with some human inte-
w xgrins 26 . The considered secondary structures were
w xpredicted by the methods of Chou and Fasman 27
w xand Garnier et al. 28 . The purified proteins showed
comparable molecular mass with the staphylococcal
 .native proteins Fig. 1B . The biological specific
activities of the native staphylococcal proteins were
previously observed to be comparable to the E. coli
recombinant proteins, thus allowing the use of the
former proteins in the following experiments.
ATR-FTIR spectra of HlgA and HlgC are shown
in Fig. 2. In all cases the amide IX band is peaked in
the region at 1634–1641 cmy1, indicating a preva-
lence of b structure, at least in part composed of
w xantiparallel b-sheet 23 . Upon introduction of Thr
for Asp at position 28 in HlgA and 30 in HlgC there
is a reduction in the absorption at 1635 cmy1 indica-
 .tive of a decrease in b-sheet Table 1 . In the case of
HlgA T28D such a decrease is compensated mainly
by an increase in b-turn structure, whereas in the
case of HlgC T30D there is an increase in the
unordered structure.
Fig. 2. Infrared-ATR spectra in the amide IX region of deuterated
films of class S components of gamma-lysins. A: HlgA; B: HlgC.
 .The spectrum solid line , seven Lorentzian component bands
 . obtained by curve-fitting thin solid lines and their sum dotted
.line , are shown in each case. A linear baseline was subtracted. In
the insets, the spectra of the point mutants described in this paper
 . dashed lines are compared to the respective wild-type solid
.lines . In both cases, the spectrum of mutant was normalised to
have the same total area as the wild-type.
3.2. Permeabilising acti˝ity on model membranes
The pairs constituting g-hemolysins HlgAqHlgB
and HlgCqHlgB were both found to have a perme-
 .abilising activity on small unilamelar vesicles SUV .
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Table 1
Secondary structure determination of gamma-lysins and mutants
by ATR-FTIR
Protein b t a r b b1 2 total
HlgA 6.7 14.6 5.9 15.8 57.0 63.7
HlgAT28D 9.6 25.4 4.5 17.0 43.4 53.0
HlgC 4.3 21.4 11.0 5.1 58.1 62.5
HlgC T30D 4.7 24.4 11.7 14.0 45.2 49.9
 .Best fitted Lorentzians see Fig. 2 were assigned to a particular
w xsecondary structure according to Byler and Susi 22 : b pertains1
to antiparallel b-sheet, b to both parallel and antiparallel b-2
sheet, a is for a-helix, t for b-turn and r for random coil or,
more in general, unordered structure. b is b plus b . Thetotal 1 2
errors, as derived from independent fittings, are within "5%.
Hence, the effect of the mutations HlgA T28D and
HlgC T30D on this activity was studied. Fig. 3A
shows the extent of calcein release measured when
95 nM of HlgA, HlgC, HlgA T28D or HlgC T30D
were incubated with PC:Cho 1:1 SUV in the presence
of the same amount of HlgB. HlgA had the highest
permeabilising activity, while the mutants were com-
pletely inactive, even at concentrations up to five
times higher than the wild-type protein data not
.shown .
The competition between HlgA T28D and HlgC
T30D and the respective wild-type proteins in the
permeabilisation of lipid vesicles was then studied.
Constant concentrations of HlgAqHlgB or HlgCq
 .HlgB were incubated with SUV PC:Cho 1:1 in the
presence of increasing amounts of HlgA T28D and
HlgC T30D, respectively. As shown in Fig. 3B, there
was a competition between the mutants and natural
proteins, which was stronger in the case of HlgA. At
the same concentration of HlgA and its mutant, cal-
cein release decreased to around 40% of control,
disappearing almost completely when HlgA T28D:
HlgA was in a 4:1 ratio. In the case of HlgC, as the
concentration of HlgC T30D increased, the release of
calcein decreased, being 15% lower when HlgC and
the mutant were equimolar, to reach 50% of the
original activity when the mutant was four times
more concentrated than the wild-type toxin. Due to
the high amount of toxins required in these experi-
ments, a complete decrease of the permeabilising
activity of HlgC could not be reached.
3.3. Hemolytic acti˝ity
The hemolytic activity of HlgA T28D and HlgC
T30D, in the presence of HlgB, was assayed on
 .rabbit red blood cells RRBC and compared with
that of the wild-type toxins. In these assays, the class
S components HlgA or HlgC and HlgB were always
added in the same concentration, both the extent of
the hemolytic activity and the maximal rate of hemol-
 .ysis, V were determined Fig. 4A,B . HlgAqHlgBmax
provoked 80% of hemolysis at a concentration 4
Fig. 3. Permeabilising activity of HlgA, HlgA T28D, HlgC and
HlgC T30D, in the presence of equimolar HlgB, on small uni-
lamellar vesicles of PC:Cho 1:1. A: Permeabilising activity,
obtained in the presence of 95 nM of each toxin and expressed as
 .the % of calcein released ns2 . Maximal release was the value
obtained when vesicles were incubated with Triton X-100. B:
direct competitions of the mutants HlgA T28D and HlgC T30D
with native HlgA and HlgC, respectively, for SUV permeabilisa-
tion. In both cases, a fixed concentration of the native toxins
31.25 nM each for HlgAqHlgB and 95 nM each for HlgCq
.HlgB was incubated with increasing concentrations of the mu-
 .tant ns2 . In this figure, the % of calcein release is represented
w x w xas a function of the ratio mutant r wild type toxin .
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Fig. 4. Titration of the hemolytic activity of HlgA, HlgA T28D,
HlgC and HlgC T30D in the presence of HlgB on rabbit red
 .blood cells ns3 . A: extent of hemolysis expressed as a
percentage of the maximal hemolysis obtained by incubating the
red blood cells with distilled water. B: maximal rate of hemolysis
 .V calculated from the kinetic curves of hemolysis. HlgB wasmax
always present at the same concentration than the S component
of the couple. The time course of the hemolysis was followed
turbidimetrically, and the final % of hemolysis and V weremax
calculated as described in Section 2.
times lower than HlgCqHlgB around 0.5 nM and 2
.nM, respectively . Titration of V indicated that, asmax
the concentration of toxins increased over 0.09 nM,
V increased as well, to finally reach a saturatingmax
value which was almost ten times higher with HlgA
qHlgB than with HlgCqHlgB.
When HlgA T28D was assayed in the presence of
HlgB, and compared with HlgA, the mutant pre-
sented only a slight hemolytic activity, 250 times
lower than that obtained with the wild-type toxin. On
the contrary, HlgC T30D was not hemolytic at any of
the assayed concentrations, indicating that this mutant
is at least 1000 times less active than the native
HlgC.
In order to determine whether the mutants HlgA
T28D and HlgC T30D were able to bind to the cell
membrane, a test of competition was performed be-
tween these mutants and the respective native toxins.
The assay was performed keeping constant the con-
centration of the native toxin, while the concentration
of the mutant was varied in a range of 5=103 times.
When RRBC were incubated with HlgCqHlgB and
increasing concentrations of HlgC T30D, the
 .hemolytic activity decreased Fig. 5A , becoming
 .around 70% of the control native proteins when
HlgC and HlgC T30D were present in equimolar
amounts. This indicated the capability of the mutant
to bind to the membrane. Similarly, the hemolytic
activity of HlgAqHlgB decreased in the presence of
increasing amounts of HlgA T28D, being around
70% when HlgA and HlgA T28D were equimolar
Fig. 5. Hemolytic assays of direct competitions between the
 .  .native toxins HlgA A and HlgC B and various concentrations
of the mutants HlgA T28D and HlgC T30D bottom ordinate
.scale . The mutants were incubated at different concentrations
 .with a fixed concentration of HlgAqHlgB 0.47 nM each or
 .HlgCqHlgB 12.5 nM each . After the addition of RRBC, the
 .hemolytic activity was measured ns2 as in Fig. 4. In each
 .panel of this figure, the % of hemolysis left ordinate scale and
 .V right ordinate scale are reported as a function of themax
concentration of the mutant. The dashed line represents the
conditions in which native toxin and mutant are present in
equimolar amounts.
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 .Fig. 5B . HlgA T28D at a concentration 300 times
higher than HlgA completely removed the hemolytic
activity of HlgA.
3.4. Leucotoxic acti˝ity
Fig. 6 shows that the pairs HlgAqHlgB and
HlgCqHlgB are both able to provoke an influx of
ethidium in target cells, indicating the formation of
pores through the membrane. HlgA T28D in associa-
Fig. 6. Determination by flow cytometry of the ethidium fluores-
cence of PMNs incubated in the presence of A: 0.75 nM HlgB
 .and either 3 nM HlgA open circles , or 3 nM HlgAq3 nM
 .HlgA T28D closed circles , or 3 nM HlgAq30 nM HlgA T28D
 .  .open triangles , or 3 nM HlgA T28D closed triangles ; B: 0.75
 .nM HlgB and either 3 nM HlgC open circles , or 3 nM HlgCq3
 .nM HlgC T30D closed circles , or 3 nM HlgCq30 nM HlgC
 .  .T30D open triangles , or 3 nM HlgC T30D closed triangles ; C:
 .0.75 nM HlgB and either 3 nM HlgC open circles , or 3nM
 .HlgC T30Dq3nM HlgC T30D closed circles , or 3 nM HlgCq
 .HlgC T30DrD36N open triangles , or 3 nM HlgC T30DrD36N
 .closed triangles .
Fig. 7. Flow cytometry analysis of the binding of different HlgA
 .  .A and HlgC B concentrations to PMNs revealed by fluores-
 . cent antibodies open circles and fluorescent HlgB closed cir-
.cles . The fluorescence intensity was expressed in % of the value
obtained for 3 nM HlgA or HlgC.
tion with HlgB did not show any ability to form
pores through the membrane of PMNs as revealed by
 .ethidium fluorescence Fig. 6A . Moreover, HlgA
T28D was able to inhibit the biological activity of
HlgA when it was ten times more concentrated than
HlgA. Three HlgC mutants HlgC T30D, HlgC
.T30DrD36N, HlgC N129K were analysed in asso-
ciation with HlgB for their biological activity on
PMNs and compared with wild HlgC. HlgC T30D
 .had lost its toxicity towards PMNs Fig. 6B as HlgA
T28D did. Although HlgC T30D was not toxic, it
inhibited the activity of HlgC on human PMNs when
 .it was ten-fold more concentrated Fig. 6B . The
parent mutant HlgC T30DrD36N showed the same
 .lack of biological activity Fig. 6C , and the same
inhibiting properties. Conversely, the mutation in
N129 had no significant consequence on the protein
 .activity data not shown . Thus, HlgC N129K did not
receive more attention. At the opposite HlgC T30D,
and HlgC T30DrD36N were shown to have lost their
 .toxicity Fig. 4 as had HlgA T28D.
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Fig. 8. Determination by flow cytometry of the fluorescence
intensity of PMNs measured in the presence of A,C: fluorescent
anti S-component antibodies, and B,D: fluorescent DTAB-HlgB.
A,B: Mean fluorescence intensities obtained for 3 nM HlgA
 .  .T28D 1 , 3 nM HlgA and 3 nM HlgA T28D 3 , 3 nM HlgA and
 .30 nM HlgA T28D 4 were expressed in % of the value obtained
 .  .for 3 nM HlgA 2 ns4 . C,D: Mean fluorescence intensities
 .obtained for 3 nM HlgC T30D 1 , 3 nM HlgC and 3 nM HlgC
 .  .T30D 3 , 3 nM HlgC and 30 nM HlgC T30D 4 were expressed
 .  .in % of the value obtained for 3 nM HlgC 2 ns4 .
The use of fluorescent antibodies indicated that the
binding of HlgA was composed by a specific and a
 .non-specific part Fig. 7A , whereas the binding of
 .HlgC seemed strictly specific Fig. 7B . The proper-
ties of these different bindings of HlgA and HlgC
will be extensively studied elsewhere. The mutated
HlgA retained its ability to bind to PMN membranes,
as revealed by the fixation of fluorescent S compo-
 .nent antibodies Fig. 8A . In fact, the amount of
fluorescent antibodies bound when HlgA was mixed
with HlgA T28D was very similar to that with HlgA
 .alone Fig. 7A but at a concentration corresponding
to the sum of the concentrations of the two proteins.
Interestingly, HlgA T28D lost the capacity to bind
HlgB as shown in Fig. 8B using DTAF-HlgB, and
this would explain why it had no pore-forming abil-
ity. On the contrary, the mutant did not inhibit the
binding of HlgB to HlgA since competition experi-
ments did not reveal a decrease in binding. Further-
more, since the results obtained for the binding of
DTAF-HlgB were comparable to those for the bind-
ing of fluorescent anti S component antibodies, one
can conclude that the non-specifically bound HlgA is
still functional, at least for the secondary binding of
HlgB.
HlgC T30D, like HlgA T28D, retained its ability
 .to bind to human PMN membranes Fig. 8C but also
competed efficiently with HlgC on its binding site.
Finally, membrane-bound HlgC T30D, like HlgA
T28D, lost its ability to bind HlgB secondarily Fig.
.8D , and thus, no pores could be formed through the
cell membranes. HlgC T30DrD36N behaved exactly
 .as HlgC T30D did data not shown .
4. Discussion
Staphylococcal leucotoxins appear to be of interest
because they operate by the sequential and synergis-
tic action of class S and class F proteins, and they are
directed mainly against the host defence cells. More-
over, despite forming a defined toxin family compris-
ing at least 8 characterised and related class S and
w xclass F proteins 1–4,29,30 , they do not share high
sequence identity with other known toxins. For exam-
ple, staphylococcal a-hemolysin and exfoliative tox-
ins harboured only 29% and 23% identity with class
S components, respectively. Exfoliative toxins are
w xrather known as serine-proteases 31 . Homologies
between a-hemolysin and leucotoxins may reflect a
w xsimilar folding of the pores formed by the toxins 32 .
However, the sequential binding of proteins constitut-
ing leucotoxins remains a fundamental mechanistic
process, and oligomerisation might be more easy to
study than for a-hemolysin because of the presence
of two different proteins.
It has to be emphasized that flow cytometry re-
vealed that pairs constituting the g-hemolysin are
pore-forming toxins as it was demonstrated for the
w xPanton-Valentine leucocidin 10 and that biological
activity of these pairs can be studied either with
PMN, RRBC and SUV. More details will appear
elsewhere concerning the biological properties of g-
hemolysin. Site-directed mutagenesis strategy ini-
tially involved a conserved predicted secondary struc-
ture within class S proteins bearing membrane affin-
ity. Mutated proteins were purified to homogeneity
and it should be noticed that hydrophobic chromatog-
w xraphy 4 was necessary to avoid cross-contamination
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with HlgB. Here, the biological effect of mutations
HlgC T30D, HlgC T30DrD36N and HlgA T28D,
that would, predictably, disrupt a conserved 13 amino
acid-long b-sheet in the N-terminal part of the class
S proteins of gamma-hemolysins from L25 to K37
.for HlgA and from W27 to K39 for HlgC , was
reported. Secondary structure evaluations from
ATR-FTIR spectra of the mutants and the wild-type
toxins were performed, indicating a decrease in b-
sheet of around 10% for the mutants, suggesting it
involves a total of about 27 residues, therefore, more
than the single predicted b-strand containing the
mutation. This suggests that the mutated strand may
belong to a region of pleated sheets. These mutations
were chosen because they represented amino acid
substitutions by residues bearing different charge but
similar steric space. Another mutation was designed
 .to integrate a positive charge HlgC N129K in a
w xshort sequence common with human integrins 26
which was not critical for biological activity.
The biological activities of pairs comprising HlgB
were dramatically affected for HlgC T30D, HlgC
T30DrD36N, and HlgA T28D. The extent of the loss
of activity could not always be determined because of
the limits in the amounts of proteins available. HlgC
T30D did not show any biological activity, neither
 .against natural membranes PMN and RRBC nor
 .against model membranes SUV , so that they are at
least 1000 times less active than HlgC. HlgA T28D
instead retained some hemolytic activity, albeit 250
times lower than that of the native toxin, but was
equally inactive on PMN and on the model of mem-
brane permeabilisation. These observations prompted
the analysis of the effective binding of these non-ac-
tive mutated proteins to the PMN membrane by a
three-step procedure. The first step implied native
versus mutated proteins competition and the determi-
nation of the biological activity by ethidium entry
into permeabilised PMN. The results were similar for
HlgC and HlgA, and clearly indicated that when
equal amounts of wild-type toxins and their respec-
tive mutants were applied in addition to HlgB; around
70 to 80% of the activity without the mutants was
retained. When mutated proteins were 10-fold more
concentrated, the biological activity was almost in-
significant as compared to that of natural toxins. The
second step was the determination of the binding of
mutated proteins by fluorescent antibodies which
showed that both the mutated HlgA and HlgC kept
their binding properties specific and non-specific for
.HlgA, specific for HlgC and could compete with
wild-type proteins on the same binding sites. There-
fore, the primary binding of class S components to
membranes was once more confirmed. The third one
was the determination of the binding of fluorescent
HlgB on the bound mutated proteins. They were both
shown to be unable to bind HlgB, but, when associ-
ated with their respective native protein, they gave
different results. HlgA T28D, even ten times more
concentrated than HlgA, did not modify the binding
of HlgB, suggesting the presence of non-specific
binding sites for HlgA for which no significant com-
petition occurred. Nevertheless, there was no opening
of pores. An explanation for this could be that the
w xpores, as for a-toxin 33 , are constituted by oligomers
including several S components where the native
toxin and its mutant could be mixed. In these
oligomers, HlgB could bind to HlgA but not to the
mutated protein, thus rendering the oligomers proba-
bly containing both HlgA and the mutated HlgA
unable to create a pore. Conversely, in the case of
 .HlgC at the concentration of 3 nM Fig. 7B , the
binding sites are nearly saturated and HlgC T30D can
compete with its parent protein, thus decreasing the
binding sites of the HlgB class F component. A
higher propensity of HlgA to make unspecific bind-
ing, presumably to the lipid matrix itself could ex-
plain its higher activity on purely lipidic vesicles.
Furthermore, the formation of inactive complex ag-
gregates containing native and mutated class S com-
ponents and class F components is the only reason-
able explanation for the competition effect observed
with SUV, where specific binding is excluded.
In conclusion, the mutated proteins seemed to bind
to the same membrane target sites as the respective
native proteins. This indicated that the mutations,
although predictably disrupting a 13 amino acid-long
 .b-sheet from W27 to K39 , did not affect profoundly
the structural conformation of the whole protein. The
loss of pore-forming activity of the mutated toxins
was shown to be due to the loss of the ability to make
an oligomer with HlgB. At this point of studies, it is
not known whether disruption of the b-sheet or the
only introduction of a negative charge are responsible
for the loss of binding of HlgB. The predicted 13
amino acid long b-sheet appears at least to have an
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essential role in the class S component-mediated
 .binding of HlgB class F component . However, the
 .mutation D36N HlgC T30DrD36N did not restore
any functional activity although, according to the
secondary structure predictions, it retained a putative
6 amino acid-long b-sheet. The latter result would
indicate either the secondary structure prediction is
fictitious, or that the restored structure is not suffi-
cient to allow the binding of HlgB, or that threonin
30 exerts a critical role in the secondary binding.
Contrary to the a-toxin where oligomers can be
w xobserved in solution 34 , major structural modifica-
tions appear to be necessary in order to favour the
secondary binding of class F component of leucotox-
ins. More detailed studies are now in progress to-
gether with topology analysis of pore-formation and
cristallographic studies.
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